Key result
Desmosomal mutation mouse models recapitulate key ARVC features, including arrhythmias and replacement fibrosis.
Why the study?
The mechanisms by which mutations in desmosomal proteins cause fibro-fatty replacement in ARVC remain to be fully elucidated.
Answers are grounded in this paper and cite their sources.
This review highlights the contributions of various mouse models over the past decade in elucidating the mechanisms of fibro-fatty replacement and pathogenesis in ARVC.
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a heart muscle disorder characterized by fibro-fatty replacement of cardiomyocytes. The cardinal manifestations are arrhythmias, sudden cardiac death, and seldom heart failure. Mutations in genes encoding desmosomal proteins and their interaction partners have been implicated in the pathogenesis of ARVC and it is now widely accepted that ARVC is a disease caused by abnormal cell-cell adhesion. The mechanism(s) by which mutations in desmosomal proteins lead to fibro-fatty replacement remains to be fully elucidated. To this aim over the last 10 years different transgenic and targeted mouse models have been developed, these models and what they have taught us will be discussed in this review.
No takes yet. Share an insight, caveat, or question.
Lodder et al. (2012) conducted a review in Arrhythmogenic right ventricular cardiomyopathy (ARVC). Mouse models of desmosomal gene mutations was evaluated. Transgenic and targeted mouse models of desmosomal gene mutations successfully recapitulate key features of arrhythmogenic right ventricular cardiomyopathy, including arrhythmias and replacement fibrosis.
Synapse has enriched 10 related papers. Consider them for comparative context: